Excessive interferon-α signaling in autoimmunity alters glycosphingolipid processing in B cells

Add time:08/02/2019    Source:sciencedirect.com

Excessive interferon-α (IFN-α) production by innate immune cells is a hallmark of autoimmune diseases. What other cell type secretes IFN-α and how IFN-α affects immune cell metabolism and homeostasis in autoimmunity are largely unclear. Here, we report that autoimmune B cells, arising from two different B cell-specific genetic lesions in mice, secrete IFN-α. In addition, IFN-α, found in abundance in autoimmunity, elicited profound changes in the B cell lipidome, increasing their expression of glycosphingolipids (GSLs) and leading to their CD1d-mediated depletion of iNKT cells in vitro and in vivo. IFN-α receptor blockade could reverse the loss of iNKT cells. Excessive stimulation of B cells with IFN-α altered the expression of enzymes that catalyze critical steps in GSL processing, increasing the expressions of glucosylceramide synthase (GCS) and globotrihexosylceramide synthase (Gb3S) but decreasing that of α-galactosidase A (α-galA). Inhibiting GCS or restoring α-galA expression prevented iNKT depletion by IFN-α-activated B cells. Taken together, our work indicated that excessive IFN-α perturbs GSL metabolism in B cells which in turn adversely affects iNKT homeostasis.

We also recommend Trading Suppliers and Manufacturers of F-9 glycosphingolipid (cas 134711-49-2). Pls Click Website Link as below: cas 134711-49-2 suppliers

Prev:Synthesis of a new glycosphingolipid, neurosporaside, from Neurospora crassa
Next:Preparation and electrophoretic separation of Bodipy-Fl-labeled glycosphingolipids)